Vident Advisory LLC Purchases 12,250 Shares of Keurig Dr Pepper, Inc $KDP

Key Points

• Vident Advisory LLC increased its position in Keurig Dr Pepper by 85.1%, purchasing an additional 12,250 shares, bringing its total holdings to 26,641 shares worth $912,000.
• Insider trading activity was noted, with Mary Beth Denooyer and Robert James Gamgort selling shares, indicating a 12.70% decrease in Denooyer's holdings and a 0.33% decrease for Gamgort.
• The company's stock has seen price target adjustments from various analysts, with Barclays raising it from $37.00 to $39.00, while HSBC lowered its target from $42.00 to $30.00.

Vident Advisory LLC increased its position in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 85.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 26,641 shares of the company's stock after acquiring an additional 12,250 shares during the quarter. Vident Advisory LLC's holdings in Keurig Dr Pepper were worth $912,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. ST Germain D J Co. Inc. purchased a new position in Keurig Dr Pepper during the first quarter worth about $27,000. WPG Advisers LLC purchased a new position in Keurig Dr Pepper during the first quarter worth about $43,000. Continuum Advisory LLC grew its position in Keurig Dr Pepper by 82.5% during the first quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock worth $46,000 after buying an additional 602 shares in the last quarter. Global Trust Asset Management LLC purchased a new position in Keurig Dr Pepper during the first quarter worth about $48,000. Finally, LRI Investments LLC grew its position in Keurig Dr Pepper by 65.6% during the fourth quarter. LRI Investments LLC now owns 1,527 shares of the company's stock worth $49,000 after buying an additional 605 shares in the last quarter. 93.99% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Barclays boosted their target price on Keurig Dr Pepper from $37.00 to $39.00 and gave the stock an "overweight" rating in a research report on Monday, July 28th. HSBC restated a "hold" rating and set a $30.00 target price (down from $42.00) on shares of Keurig Dr Pepper in a research report on Tuesday, August 26th. Jefferies Financial Group set a $41.00 target price on Keurig Dr Pepper in a research report on Monday, August 25th. Deutsche Bank Aktiengesellschaft dropped their price target on Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating for the company in a research note on Tuesday, August 26th. Finally, UBS Group cut their price objective on Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating for the company in a report on Wednesday, August 27th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $38.38.

Insider Activity

In related news, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction dated Thursday, July 17th. The stock was sold at an average price of $33.66, for a total transaction of $403,920.00. Following the completion of the sale, the insider directly owned 82,511 shares in the company, valued at $2,777,320.26. This represents a 12.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert James Gamgort sold 7,601 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $35.91, for a total value of $272,951.91. Following the sale, the director owned 2,284,568 shares of the company's stock, valued at $82,038,836.88. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 459,601 shares of company stock valued at $15,228,872 over the last 90 days. 0.40% of the stock is currently owned by company insiders.

Keurig Dr Pepper Price Performance

KDP opened at $29.25 on Friday. The stock has a 50-day moving average price of $33.03 and a 200-day moving average price of $33.51. Keurig Dr Pepper, Inc has a 12-month low of $28.58 and a 12-month high of $38.28. The company has a current ratio of 0.64, a quick ratio of 0.40 and a debt-to-equity ratio of 0.56. The stock has a market capitalization of $39.73 billion, a P/E ratio of 26.12, a PEG ratio of 1.59 and a beta of 0.47.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its earnings results on Thursday, July 24th. The company reported $0.49 earnings per share for the quarter, meeting the consensus estimate of $0.49. The company had revenue of $4.16 billion during the quarter, compared to analysts' expectations of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.Keurig Dr Pepper's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.45 EPS. Equities analysts predict that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current fiscal year.

Keurig Dr Pepper Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.